Zixiang Gao

Key Laboratory Of Medical Molecular Virology
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus.

Identification and characterization of host factor VCPIP1 as a multi-functional positive regulator of hepatitis B virus.

Journal: Journal of virology
Published: November 04, 2024

Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.

Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein.

Journal: PLoS pathogens
Published: August 13, 2024

Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics.

Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics.

Journal: Acta biochimica et biophysica Sinica
Published: April 24, 2024

Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.

Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.

Journal: Journal of virology
Published: January 16, 2024

Establishment and characterization of a novel reverse genetic system of BK polyomavirus.

Establishment and characterization of a novel reverse genetic system of BK polyomavirus.

Journal: Journal of medical virology
Published: June 04, 2023

Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.

Lipid nanoparticle-mediated delivery of IL-21-encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence.

Journal: Journal of medical virology
Published: March 17, 2023

Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.

Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.

Journal: Antiviral research
Published: April 12, 2022

Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection.

Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection.

Journal: Virologica Sinica
Published: January 24, 2022

High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein.

High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein.

Journal: Nucleic acids research
Published: September 23, 2021

Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence.

Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence.

Journal: Antiviral research
Published: January 20, 2021

Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection.

Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection.

Journal: Theranostics
Published: February 08, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026